All AbMole products are for research use only, cannot be used for human consumption.
5-BrdU is a synthetic thymidine analog; incorporated into DNA during replication. 5-BrdU (Bromodeoxyuridine) is used in assays for cell proliferation. 5-BrdU (BrdU) induces a progressive, dose-responsive suppression of cancer cell line and cancer stem cell population expansion RG2 rat glioma cells. In H9 cells and BJ fibroblasts, bromodeoxyuridine alters the cell cycle profile. BrdU is stably integrated into the DNA, and thus can be used in assessment of cell proliferation and other cell procession.
Nucleic Acids Res. 2024 Jun 20;58(19):8182-8193.
YY1 is involved in homologous recombination inhibition at guanine quadruplex sites in human cells
5-BrdU purchased from AbMole
Cancer Cell Int. 2023 Oct 16;23(1):243.
Serum exosomal hsa-circ-0004771 modulates the resistance of colorectal cancer to 5-fluorouracil via regulating miR-653/ZEB2 signaling pathway
5-BrdU purchased from AbMole
Int Immunopharmacol. 2023 Dec 2;126:111303.
Astragalus polysaccharides promote neural stem cells-derived oligodendrogenesis through attenuating CD8+T cell infiltration in experimental autoimmune encephalomyelitis
5-BrdU purchased from AbMole
| Molecular Weight | 307.1 |
| Formula | C9H11BrN2O5 |
| CAS Number | 59-14-3 |
| Solubility (25°C) | DMSO 50 mg/mL Water 9 mg/mL |
| Storage | 2-8°C, protect from light, dry, sealed |
| Related DNA/RNA Synthesis Products |
|---|
| Clofarabine
Clofarabine inhibits the enzymatic activities of ribonucleotide reductase (IC50 = 65 nM) and DNA polymerase. |
| Gemcitabine Hydrochloride
Gemcitabine (Gemzar, LY188011) inhibits DNA synthesis with an IC50 of 0.06 µM. |
| Nelarabine
Nelarabine is a novel purine antimetabolite antineoplastic agent. |
| Mizoribine
Mizoribine (Bredinin) is an imidazole nucleoside and an immunosuppressive agent with an IC50 of approximately 100 μM. Mizoribine inhibits replication of SARS-CoV with IC50s of 3.5 μg/mL and 16 μg/mL for SARS-CoV Frankfurt-1 and SARS-CoV HKU39849, respectively. |
| Capecitabine
Capecitabine is an orally-administered chemotherapeutic agent. Capecitabine is a precursor, that is enzymatically converted to 5-fluorouracil in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Capecitabine may inhibit cytochrome CYP2C9 enzyme, and therefore increase levels of substrates such as phenytoin and other substrates of CYP2C9. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
